Viewing Study NCT03933761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:15 PM
Ignite Modification Date: 2026-01-25 @ 1:50 AM
Study NCT ID: NCT03933761
Status: WITHDRAWN
Last Update Posted: 2021-08-10
First Post: 2019-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy
Sponsor: Australia New Zealand Gynaecological Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Carcinosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High grade serous View
None ABCB1 fusion positive View
None BRCA 1/2 reversion negative View
None Platinum resistant View
None Platinum sensitive View